Ensysce Biosciences, Inc. - Common Stock (ENSC)
3.2900
-0.0200 (-0.60%)
NASDAQ · Last Trade: Apr 26th, 11:48 PM EDT
Via Benzinga · April 24, 2025
Via Benzinga · April 24, 2025
Via Benzinga · April 24, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · April 23, 2025
Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.
Via Stocktwits · April 15, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 10, 2025
Via Benzinga · March 13, 2025

Via Benzinga · December 4, 2024

Via Benzinga · November 13, 2024

Via Benzinga · November 7, 2024

Via Benzinga · November 7, 2024

Via Benzinga · November 7, 2024

Via Benzinga · October 31, 2024

Via Benzinga · October 31, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 30, 2024